In recent years, U.S. options have seen significant growth in volume and overall interest from institutional investors, as these derivative products allow for greater risk management and downside ...

INVO Fertility (IVF), formerly known as NAYA Biosciences (NAYA), confirmed it will begin trading under the new symbol “IVF” at the market open ...

ZyVersa CEO Stephen Glover said, “ZyVersa is developing Inflammasome ASC Inhibitor IC 100 for treatment of chronic inflammatory diseases, with ...